DTRAX® technology fills critical gaps in the continuum of traditional cervical spine care.
DTRAX is a family of products designed for use in cervical fusion surgery.
Products include instruments, intervertebral cages, orthopedic bone screws, and allograft implants.
A privately-held medical device company developing innovative solutions addressing the $1 billion worldwide cervical spine market. The company's focus is on commercializing the DTRAX platform of tissue-sparing cervical implants and instruments to treat cervical degenerative disc disease through indirect decompression, stabilization and fusion.
David Cash (Principal, Stanmore Medical Investments)
Robert Thomas (Managing Director, Aphelion Capital)
Jeff Smith (CEO, Providence Medical Technology)
Art Taylor (COO and CFO, Topera Inc.)
Jeff Smith (CEO, Co-Founder, Director)
Jason Hoffman (VP, Global Sales)
Janet Hudnall (VP, Global Marketing)
Edward Liou (VP, Engineering and Operations)
Neil O’Connell (VP, Finance)
ISASS16 - International Society for the Advancement of Spine Surgery
April 6-8, 2016 - Las Vegas, NV
Providence Medical Technology, Inc.
1331 N. California Blvd Suite 320
Walnut Creek, CA 94596
Tel: (415) 923-9376
Fax: (415) 923-9377